split dosing tirzepatide Tirzepatide Dosage for Weight Loss

Results at 68 weeks: 40.4% of CagriSema participants lost 25% or more of their body weight 91.9% lost at least 5% Blood pressure fell by 10.9 mmHg systolic on average About 40% of participants reduced or stopped blood pressure medications 87.7% of those with prediabetes at baseline achieved normal blood sugar Results were published in the New England Journal of Medicine and presented at the American Diabetes Associations 2026 Scientific Sessions

Commensal Neisseria cinerea impairs Neisseria meningitidis microcolony development and reduces pathogen colonisation of epithelial cells

10.1016/j.chembiol.2017.08.028 105 LuftD.SchmllingR

Tirzepatide is contraindicated in pregnancy, and weight gain could be an early sign of pregnancy